Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedłużonym uwalnianiu
DHM/EPH/01/2022
Phase 3 small_molecule active
Quick answer
Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedłużonym uwalnianiu for Menopause, sleep disorders in the postmenopausal period is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Menopause, sleep disorders in the postmenopausal period
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active